|
[에너지경제신문 나유라 기자] Pascal Sorio AstraZeneca, CEO of AstraZeneca, said Europe has the lowest productivity in the world for the vaccine raw material for the novel coronavirus infection (Corona 19). As a result, it explained that the plan to produce the Corona 19 vaccine in Europe was two months behind the original plan.
In an interview with the German Daily Belt on the 27th (local time), CEO Pascal Sorio AstraZeneca said, “The vaccine production is carried out in two stages. First, the vaccine itself is produced and then put in ampoules.” “In the Netherlands, Belgium, and later ampoules in Germany and Italy, this process is fine.”
The problem is that productivity is poor in cultivating raw materials.
CEO Sorio said, “We put the virus in a large tank that can hold up to 2000 liters and cultivate the raw materials for the production of Corona 19 vaccine. In the European tank, the productivity of raw materials is the lowest in the world.
CEO Sorio denied that AstraZeneca deliberately delayed supply to the EU and was wrong with the allegations of exporting to other regions.
This is because the EU’s vaccine order was three months behind the UK.
Regarding the delay in the supply of vaccines to the EU, he said, “We said we’d do our best, but we don’t have a contractual supply obligation. We like our ambitious goals, but we didn’t endorse them.” did.
CEO Sorio emphasized that AstraZeneca’s COVID-19 vaccine is a completely wrong number with respect to German media reports that only 8% of those aged 65 and older are effective.
At the same time, regarding how effective the COVID-19 vaccine is for the elderly, he said, “Oxford University did not test for the elderly during the first clinical trial due to an ethical issue.” “There are detailed data to prove that they do.”